{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T04:22:59Z","timestamp":1778559779471,"version":"3.51.4"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,2,1]]},"DOI":"10.1095\/biolreprod.103.023051","type":"journal-article","created":{"date-parts":[[2004,10,20]],"date-time":"2004-10-20T18:30:50Z","timestamp":1098297050000},"page":"458-464","source":"Crossref","is-referenced-by-count":31,"title":["Anti-Inflammatory and Utero-Relaxant Effects in Human Myometrium of New Generation Phosphodiesterase 4 Inhibitors"],"prefix":"10.1093","volume":"70","author":[{"given":"St\u00e9phanie","family":"Oger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9line","family":"M\u00e9hats","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary S.","family":"Barnette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franc\u0327oise","family":"Ferr\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominique","family":"Cabrol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Jos\u00e8phe","family":"Leroy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"key\n\t\t\t\t20170224180724_R1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/mrdd.10008","article-title":"Intrauterine infection and prematurity.","volume":"8","year":"2002","journal-title":"Ment Retard Dev Disabil Res Rev"},{"key":"key\n\t\t\t\t20170224180724_R2","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/S0002-9378(96)70450-7","article-title":"Intrauterine infection and the effects of inflammatory mediators on prostaglandin production by myometrial cells from pregnant women.","volume":"174","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"key\n\t\t\t\t20170224180724_R3","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1056\/NEJM200005183422007","article-title":"Intrauterine infection and preterm delivery.","volume":"342","year":"2000","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170224180724_R4","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1126\/science.184.4132.19","article-title":"Modulation of inflammation and immunity by cyclic AMP.","volume":"184","year":"1974","journal-title":"Science"},{"key":"key\n\t\t\t\t20170224180724_R5","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0165-6147(97)90613-1","article-title":"Phosphodiesterase (PDE)4 inhibitors: anti-inflammatory drugs of the future?.","volume":"18","year":"1997","journal-title":"Trends Pharmacol Sci"},{"key":"key\n\t\t\t\t20170224180724_R6","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/S0192-0561(00)00046-1","article-title":"Tumor necrosis factor has positive and negative self-regulatory feedback cycles centered around cAMP.","volume":"22","year":"2000","journal-title":"Int J Immunopharmacol"},{"key":"key\n\t\t\t\t20170224180724_R7","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1203\/00006450-199811000-00001","article-title":"Regulation of uterine smooth muscle function during gestation.","volume":"44","year":"1998","journal-title":"Pediatr Res"},{"key":"key\n\t\t\t\t20170224180724_R8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj20021698","article-title":"PDE4 cAMP phosphodiesterases: modular enzymes that orchestrate signalling cross-talk, desensitization and compartmentalization.","volume":"370","year":"2003","journal-title":"Biochem J"},{"key":"key\n\t\t\t\t20170224180724_R9","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/0898-6568(94)90087-6","article-title":"Isolation and characterization of the rolipram-sensitive cyclic AMP-specific phosphodiesterase (type IV PDE) in human term myometrium.","volume":"6","year":"1994","journal-title":"Cell Signal"},{"key":"key\n\t\t\t\t20170224180724_R10","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.2174\/1381612023394665","article-title":"Recent advances in PDE4 inhibitors as immunoregulators and anti-inflammatory drugs.","volume":"8","year":"2002","journal-title":"Curr Pharm Des"},{"key":"key\n\t\t\t\t20170224180724_R11","first-page":"193","article-title":"Phosphodiesterase 4 (PDE4) inhibitors in asthma and chronic obstructive pulmonary disease (COPD).","volume":"53","year":"1999","journal-title":"Prog Drug Res"},{"key":"key\n\t\t\t\t20170224180724_R12","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/S0006-2952(02)00903-6","article-title":"Comparison of inhibition of ovalbumin-induced bronchoconstriction in guinea pigs and in vitro inhibition of tumor necrosis factor-alpha formation with phosphodiesterase 4 (PDE4) selective inhibitors.","volume":"63","year":"2002","journal-title":"Biochem Pharmacol"},{"key":"key\n\t\t\t\t20170224180724_R13","doi-asserted-by":"crossref","first-page":"4909","DOI":"10.4049\/jimmunol.155.10.4909","article-title":"Cyclic nucleotide phosphodiesterase type IV participates in the regulation of IL-10 and in the subsequent inhibition of TNF-alpha and IL-6 release by endotoxin-stimulated macrophages.","volume":"155","year":"1995","journal-title":"J Immunol"},{"key":"key\n\t\t\t\t20170224180724_R14","first-page":"1313","article-title":"Differential regulation of human monocyte-derived TNF alpha and IL-1 beta by type IV cAMP-phosphodiesterase (cAMP-PDE) inhibitors.","volume":"272","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"key\n\t\t\t\t20170224180724_R15","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1177\/00912700222011328","article-title":"The new phosphodiesterase 4 inhibitor roflumilast is efficacious in exercise-induced asthma and leads to suppression of LPS-stimulated TNF-alpha ex vivo.","volume":"42","year":"2002","journal-title":"J Clin Pharmacol"},{"key":"key\n\t\t\t\t20170224180724_R16","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0006-2952(89)90142-1","article-title":"Correlation between selective inhibition of the cyclic nucleotide phosphodiesterases and the contractile activity in human pregnant myometrium near term.","volume":"38","year":"1989","journal-title":"Biochem Pharmacol"},{"key":"key\n\t\t\t\t20170224180724_R17","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s002109900092","article-title":"Pharmacological and biochemical study on the effects of selective phosphodiesterase inhibitors on human term myometrium.","volume":"360","year":"1999","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"key\n\t\t\t\t20170224180724_R18","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1210\/endo.140.7.6847","article-title":"Selective up-regulation of phosphodiesterase-4 cyclic adenosine 3\u2032,5\u2032-monophosphate (cAMP)-specific phosphodiesterase variants by elevated cAMP content in human myometrial cells in culture.","volume":"140","year":"1999","journal-title":"Endocrinology"},{"key":"key\n\t\t\t\t20170224180724_R19","first-page":"817","article-title":"Pregnancy induces a modulation of the cAMP phosphodiesterase 4-conformers ratio in human myometrium: consequences for the utero-relaxant effect of PDE4-selective inhibitors.","volume":"292","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"key\n\t\t\t\t20170224180724_R20","doi-asserted-by":"crossref","first-page":"5524","DOI":"10.1210\/jc.2002-020575","article-title":"Interleukin-1beta induces phosphodiesterase 4B2 expression in human myometrial cells through a prostaglandin E(2)- and cyclic adenosine 3\u2032,5\u2032-monophosphate-dependent pathway.","volume":"87","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20170224180724_R21","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1038\/sj.bjp.0702911","article-title":"Suppression of human inflammatory cell function by subtype-selective PDE4 inhibitors correlates with inhibition of PDE4A and PDE4B.","volume":"128","year":"1999","journal-title":"Br J Pharmacol"},{"key":"key\n\t\t\t\t20170224180724_R22","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1517\/13543784.10.7.1361","article-title":"Cilomilast: a second generation phosphodiesterase 4 inhibitor for asthma and chronic obstructive pulmonary disease.","volume":"10","year":"2001","journal-title":"Expert Opin Investig Drugs"},{"key":"key\n\t\t\t\t20170224180724_R23","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0076-6879(88)59045-6","article-title":"Assay of cyclic nucleotide phosphodiesterase using radiolabeled and fluorescent substrates.","volume":"159","year":"1988","journal-title":"Methods Enzymol"},{"key":"key\n\t\t\t\t20170224180724_R24","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1159\/000298968","article-title":"Cyclic 3\u2032:5\u2032-nucleotide phosphodiesterase in human myometrium at the end of pregnancy: partial purification and characterization of the different soluble isoenzymes.","volume":"20","year":"1985","journal-title":"Gynecol Obstet Invest"},{"key":"key\n\t\t\t\t20170224180724_R25","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.","volume":"72","year":"1976","journal-title":"Anal Biochem"},{"key":"key\n\t\t\t\t20170224180724_R26","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1159\/000298802","article-title":"Characterization by DEAE-cellulose chromatography of a single molecular form of cyclic nucleotide phosphodiesterase in the myometrium of nonpregnant women.","volume":"24","year":"1987","journal-title":"Gynecol Obstet Invest"},{"key":"key\n\t\t\t\t20170224180724_R27","first-page":"267","article-title":"Anti-inflammatory and immunomodulatory potential of the novel PDE4 inhibitor roflumilast in vitro.","volume":"297","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"key\n\t\t\t\t20170224180724_R28","first-page":"420","article-title":"SB 207499 (Ariflo), a potent and selective second-generation phosphodiesterase 4 inhibitor: in vitro anti-inflammatory actions.","volume":"284","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"key\n\t\t\t\t20170224180724_R29","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/S0002-9378(13)90489-0","article-title":"Systemic and local cytokine profiles in endotoxin-induced preterm parturition in mice.","volume":"170","year":"1994","journal-title":"Am J Obstet Gynecol"},{"key":"key\n\t\t\t\t20170224180724_R30","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/S0002-9378(96)70460-X","article-title":"Repeated administration of low-dose lipopolysaccharide induces preterm delivery in mice: a model for human preterm parturition and for assessment of the therapeutic ability of drugs against preterm delivery.","volume":"174","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"key\n\t\t\t\t20170224180724_R31","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0002-9378(88)90501-7","article-title":"Assay of bacterial endotoxin (lipopolysaccharide) in human amniotic fluid: potential usefulness in diagnosis and management of preterm labor.","volume":"159","year":"1988","journal-title":"Am J Obstet Gynecol"},{"key":"key\n\t\t\t\t20170224180724_R32","first-page":"4859","article-title":"Formation of proinflammatory cytokines in human term myometrium is stimulated by lipopolysaccharide but not by corticotropin-releasing hormone.","volume":"85","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20170224180724_R33","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1476-5381.1996.tb15450.x","article-title":"Evidence that cyclic AMP phosphodiesterase inhibitors suppress TNF alpha generation from human monocytes by interacting with a \u2018low-affinity\u2019 phosphodiesterase 4 conformer.","volume":"118","year":"1996","journal-title":"Br J Pharmacol"},{"key":"key\n\t\t\t\t20170224180724_R34","doi-asserted-by":"crossref","first-page":"7628","DOI":"10.1073\/pnas.122041599","article-title":"Induction of the cyclic nucleotide phosphodiesterase PDE4B is essential for LPS-activated TNF-alpha responses.","volume":"99","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t20170224180724_R35","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/jlb.63.1.101","article-title":"Anti-inflammatory activities of cAMP-elevating agents: enhancement of IL-10 synthesis and concurrent suppression of TNF production.","volume":"63","year":"1998","journal-title":"J Leukoc Biol"},{"key":"key\n\t\t\t\t20170224180724_R36","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/jlb.56.1.27","article-title":"Interaction of nuclear proteins with an AP-1\/CRE-like promoter sequence in the human TNF-alpha gene.","volume":"56","year":"1994","journal-title":"J Leukoc Biol"},{"key":"key\n\t\t\t\t20170224180724_R37","doi-asserted-by":"crossref","first-page":"4712","DOI":"10.1128\/JVI.72.6.4712-4720.1998","article-title":"Inhibition of phosphodiesterase type IV suppresses human immunodeficiency virus type 1 replication and cytokine production in primary T cells: involvement of NF-kappaB and NFAT.","volume":"72","year":"1998","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20170224180724_R38","first-page":"753","article-title":"Phosphodiesterase 4 inhibitors prevent cytokine secretion by T lymphocytes by inhibiting nuclear factor-kappaB and nuclear factor of activated T cells activation.","volume":"299","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"key\n\t\t\t\t20170224180724_R39","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/humrep\/15.1.229","article-title":"Leukocytes infiltrate the myometrium during human parturition: further evidence that labour is an inflammatory process.","volume":"14","year":"1999","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20170224180724_R40","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1124\/mol.55.1.50","article-title":"Phosphodiesterase 4B gene transcription is activated by lipopolysaccharide and inhibited by interleukin-10 in human monocytes.","volume":"55","year":"1999","journal-title":"Mol Pharmacol"},{"key":"key\n\t\t\t\t20170224180724_R41","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1124\/mol.56.1.170","article-title":"Phosphodiesterase 4B2 is the predominant phosphodiesterase species and undergoes differential regulation of gene expression in human monocytes and neutrophils.","volume":"56","year":"1999","journal-title":"Mol Pharmacol"},{"key":"key\n\t\t\t\t20170224180724_R42","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1053\/sper.2001.26417","article-title":"A systematic approach to the management of preterm labor.","volume":"25","year":"2001","journal-title":"Semin Perinatol"},{"key":"key\n\t\t\t\t20170224180724_R43","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1124\/jpet.301.1.241","article-title":"Pharmacological profile of a novel phosphodiesterase 4 inhibitor, 4-(8-benzo [1,2,5]oxadiazol-5-yl-[1,7]naphthyridin-6-yl)-benzoic acid (NVP-ABE171), a 1,7-naphthyridine derivative, with anti-inflammatory activities.","volume":"301","year":"2002","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Biology of Reproduction"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/biolreprod\/article-pdf\/70\/2\/458\/10588909\/biolreprod0458.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T16:38:04Z","timestamp":1682786284000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/biolreprod\/article\/2712729\/Anti-Inflammatory"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,2,1]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,2,1]]}},"URL":"https:\/\/doi.org\/10.1095\/biolreprod.103.023051","relation":{},"ISSN":["0006-3363","1529-7268"],"issn-type":[{"value":"0006-3363","type":"print"},{"value":"1529-7268","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,2,1]]}}}